Gluconeogenic and glucose-regulatory pathways

Gluconeogenic and glucose-regulatory pathways refer to the complex network of biochemical reactions and signaling cascades that maintain systemic glucose homeostasis. Gluconeogenesis is the metabolic process by which the body produces glucose from non-carbohydrate precursors, such as lactate, glycerol, and glucogenic amino acids, primarily occurring in the liver and to a lesser extent in the kidney cortex (StatPearls, 2023). These pathways are regulated by a delicate balance of hormones, where insulin acts as the primary inhibitor of glucose production, while glucagon, cortisol, and catecholamines act as stimulators (NCBI Bookshelf, 2022). In pathological states like Type 2 Diabetes Mellitus, these pathways become dysregulated, leading to excessive hepatic glucose production and chronic hyperglycemia (PubMed, 2021). Therapeutic strategies often target specific enzymes within these pathways, such as glucose-6-phosphatase or fructose-1,6-bisphosphatase, or utilize agents like metformin to activate AMPK and suppress gluconeogenic gene expression (Nature Reviews Endocrinology, 2020). Maintaining the balance of these pathways is critical for preventing both hypoglycemia and the long-term complications of hyperglycemia. Modern drug development also explores the modulation of transcription factors like FoxO1 and CREB that control the expression of gluconeogenic genes. Overall, these pathways represent a central axis in metabolic health and a primary focus for anti-diabetic pharmacology.

Other names

GluconeogenesisGlucose homeostasisHepatic glucose productionGlucose metabolismGlucose-regulatory pathways

Pharmacological agents modulate these pathways by inhibiting rate-limiting gluconeogenic enzymes, activating energy-sensing kinases like AMPK to suppress gene expression, or enhancing the action of glucose-lowering hormones like insulin and GLP-1 (Nature Reviews Endocrinology, 2020).